In an imaging landscape where 64 percent of recommendations for supplemental screening are ignored by referring physicians, radiologists face a legal question: To what extent are they responsible for making sure colleagues follow through on their advice?

California’s breast density law is scheduled to expire in January 2019. To gauge the feelings of people most affected by this possible expiration, Are You Dense and Are You Dense Advocacy surveyed more than 500 women between the ages of 40 and 74 who live in California and have had a mammogram within the last two years.

Musculoskeletal (MSK) ultrasound rarely misses significant imaging findings, making follow-up MRI examinations largely unnecessary, according to a new study published by the Journal of the American College of Radiology.

There is “no statistically significant difference” in radiologist performance metrics when screening digital breast tomosynthesis (DBT) examinations immediately compared to screening them later when the patient has left the facility, according to a new study published by Academic Radiology.

Children see a higher rate of nodule malignancy in the thyroid than adults, clinicians confirmed in a recent Radiology study. Also, despite a handful of similarities in signs and symptoms, the younger demographic is faced with some unique biomarkers.

Automated Breast Volume Scanner (ABVS) evaluation is close to matching traditional breast MRI in assessing tumor diameter and volume—and it’s leaving patients more satisfied and comfortable than its conventional counterpart, a study published in the European Journal of Radiology suggests.

Dedicated symposiums—even ones limited to a day or less—could be key mediums for raising awareness of interventional radiology among medical students and recruiting future radiology leaders, Ohio State University researchers reported in Current Problems in Diagnostic Radiology this April.

The Medical Imaging & Technology Alliance (MITA) announced Tuesday, May 8, that Lisa Spellman has been hired as the organization’s general-secretary for DICOM international. Spellman will be responsible for leading and managing “operational affairs for DICOM stakeholders worldwide.”

Seven years after the FDA approved the first tomosynthesis device for breast cancer screening, adoption rates for digital breast tomosynthesis (DBT) remain on an upswing. Earlier this year the agency reported a nearly 30 percent increase of certified mammography facilities offering DBT—aka “3D mammography,” aka “tomo”—over just the past year (from 3,178 facilities in March 2017 to 4,074 in March 2018).